Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.
Walsh KS, Janusz J, Wolters PL, Martin S, Klein-Tasman BP, Toledo-Tamula MA, Thompson HL, Payne JM, Hardy KK, de Blank P, Semerjian C, Gray LS, Solomon SE, Ullrich N; REiNS International Collaboration.
Walsh KS, et al.
Neurology. 2016 Aug 16;87(7 Suppl 1):S21-30. doi: 10.1212/WNL.0000000000002928.
Neurology. 2016.
PMID: 27527646
Free PMC article.